This is a terminal delisting event — the securities are being removed from Nasdaq under Rule 12d2-2(a)(3) for matured/retired securities, not a transfer to OTC. Common stock holders should expect no further trading venue and likely zero recovery. Any remaining positions should be closed immediately if still tradeable; the filing suggests the company has redeemed or retired all outstanding shares.
Price Chart
Executive Summary
Nasdaq filed a Form 25-NSE to remove AtaiBeckley Inc. (ATAI) common stock from listing and registration under Section 12(b) of the Securities Exchange Act of 1934, effective September 11, 2026. The delisting is based on Rule 12d2-2(a)(3), which covers securities that have been matured, redeemed, or retired. This filing confirms the company's securities are being withdrawn from Nasdaq, likely as part of a going-private transaction or corporate wind-down, representing a terminal event for public market investors.
Key Facts
- Nasdaq filed Form 25-NSE to delist AtaiBeckley Inc. common stock under Rule 12d2-2(a)(3) (matured, redeemed, or retired securities)
- Filing date: September 11, 2026; effective immediately upon filing
- The delisting is based on the securities being matured, redeemed, or retired, not a failure to meet listing standards
- Cross-filing context includes delisting-notice, exchange-delisting-deregistration, exchange-delisting-going-private, and exchange-delisting-late-filing contexts — all flagged as AMPLIFIER combos
- Company recently changed name from atai Life Sciences Luxembourg S.A. to AtaiBeckley Inc. on August 11, 2025
Financial Impact
Delisting from Nasdaq — all public equity holders lose exchange-traded liquidity; securities are being removed from registration entirely under a matured/retired basis, implying zero residual value for common stock
Risk Factors
- Complete loss of equity value for common stockholders — securities are being removed from registration as matured/retired
- No OTC trading expected — delisting under 12d2-2(a)(3) implies securities no longer exist as outstanding
- Potential for litigation from shareholders if the going-private process was contested or undervalued
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 25-NSE Filing (Primary) | 0001354457-26-000870 |
| Document: 0001354457-26-000870-index-headers.html | 0001354457-26-000870 |
| Document: 0001354457-26-000870-index.html | 0001354457-26-000870 |
| Document: 0001354457-26-000870.txt | 0001354457-26-000870 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | 25-NSE | $7.30 awaiting T+20 | awaiting T+20 | — | — |
Aug 10, 2026 7w ago | DEFM14A | $7.25 $7.28 | ▲ +0.41% | ▲ +1.33% | — |
Aug 9, 2026 7w ago | Institutional Cluster | $7.25 $7.28 | ▲ +0.41% | ▲ +1.33% | — |
Jul 16, 2026 11w ago | DEFA14A / 8-K | $7.15 $7.25 | ▲ +1.40% | ▼ −2.22% | — |
Jul 7, 2026 12w ago | 144 | $5.17 $7.22 | ▲ +39.65% | ▲ +36.38% | — |
Jul 6, 2026 12w ago | Press Release | $4.96 $7.18 | ▲ +44.76% | ▲ +45.32% | — |
Jun 26, 2026 14w ago | 144 | $5.36 $7.18 | ▲ +33.96% | ▲ +34.23% | — |
Jun 25, 2026 14w ago | 144 | $5.29 $7.17 | ▲ +35.54% | ▲ +34.28% | — |
Jun 3, 2026 17w ago | 8-K | $4.53 $5.19 | ▲ +14.57% | ▲ +15.57% | — |
May 12, 2026 20w ago | Press Release | $4.15 $3.78 | ▼ −8.92% | ▼ −7.19% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access